A phase I study of the combination of intravenous reovirus type 3 Dearing and gemcitabine in patients with advanced cancer.

Translated title of the contribution: A phase I study of the combination of intravenous reovirus type 3 Dearing and gemcitabine in patients with advanced cancer.

M.P.J.K. Lolkema, H.T. Arkenau, K. Harrington, P. Roxburgh, R. Morrison, V. Roulstone, K. Twigger, M. Coffey, K. Mettinger, G. Gill, T.R. Evans, J.S. de Bono

Research output: Contribution to journalArticleAcademicpeer-review

Translated title of the contributionA phase I study of the combination of intravenous reovirus type 3 Dearing and gemcitabine in patients with advanced cancer.
Original languageUndefined/Unknown
Pages (from-to)581-588
Number of pages8
JournalClinical Cancer Research
Volume17
Issue number3
Publication statusPublished - 2011

Cite this